Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

Healthcare Medical Devices
MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.


TSXV:MIR - Post by User

MedMira Inc > Test
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(15)
•••
Comment by Jennifer2020on Nov 01, 2020 2:39am
170 Views
Post# 31819665

RE:Test

RE:TestThanks for that Rossaporino, a comment in that article highlights the superiority of Medmira's RealCovid 19 test which detects the third Antigen IgA as well.  Medmira should highlight the fact IgA is the earliest to appear, if this guy is accurate about that fact:

Sivaram Rajagopalan
At the moment both the IgG/IgM and Antigen rapid tests are all showing poor sensitivity, especially if earlier in the infection cycle. My group are about to release a triple anti-body test kit, IgG/IgM & IgA. Much of the published science shows that IgA is high much earlier in the infection cycle than IgM/G. Expectations are it should improve sensitivity. But I think the proof is in the eating of the pudding! We are doing testing in some Indian hospitals at present involved with COVID screening.
LikeReply13w

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities